SCHEMBL25066882

SCHEMBL25066882

CC(C)(C)OC(=O)n1cccc1-c1ccnc(F)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 1/20 0.50
▸ HSP90AB1 P08238 1/20 0.50
▸ PIK3CA P42336 2/20 0.45
▸ PIK3R1 P27986 1/20 0.45
▸ TNK2 Q07912 1/20 0.44
▸ ATR Q13535 1/20 0.42
▸ MET P08581 1/20 0.42
▸ AXL P30530 1/20 0.42
▸ MERTK Q12866 1/20 0.42
▸ AAK1 Q2M2I8 1/20 0.39
▸ TBK1 Q9UHD2 1/20 0.38
▸ CFTR P13569 1/20 0.36
▸ USP30 Q70CQ3 1/20 0.36
▸ BUB1 O43683 1/20 0.36
▸ BCHE P06276 1/20 0.35
▸ ACLY P53396 1/20 0.35
▸ POLB P06746 1/20 0.34
▸ PIK3CD O00329 1/20 0.34
▸ ABL1 P00519 1/20 0.34
▸ EGFR P00533 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29797501 1.00 HSP90AA1 (0.50) HSP90AA1HSP90AB1PIK3CAPIK3R1TNK2
SCHEMBL30701096 0.82 HSP90AA1 (0.52) HSP90AA1HSP90AB1PIK3CAPIK3R1TNK2
SCHEMBL15417083 0.80 HSP90AA1 (0.52) HSP90AA1HSP90AB1PIK3CAPIK3R1TNK2
SCHEMBL19349591 0.79 HSP90AA1 (0.52) HSP90AA1HSP90AB1PIK3CAPIK3R1TNK2
SCHEMBL12450000 0.78 HSP90AA1 (0.52) HSP90AA1HSP90AB1PIK3CAPIK3R1TNK2
SCHEMBL24696638 0.77 HSP90AA1 (0.56) HSP90AA1HSP90AB1PIK3CAPIK3R1TNK2
SCHEMBL24696685 0.77 HSP90AA1 (0.47) HSP90AA1HSP90AB1PIK3CAPIK3R1TNK2
SCHEMBL23416981 0.77 HSP90AA1 (0.53) HSP90AA1HSP90AB1PIK3CAPIK3R1TNK2
SCHEMBL29797892 0.77 HSP90AA1 (0.53) HSP90AA1HSP90AB1PIK3CAPIK3R1TNK2
SCHEMBL16881436 0.77 HSP90AA1 (0.45) HSP90AA1HSP90AB1PIK3CAPIK3R1TNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230058961-A1 SUBSTITUTED HETEROCYCLICS WITH THERAPEUTIC ACTIVITY IN HIV NATIONAL INSTITUTES OF HEALTH 2023-02-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230058961-A1 SUBSTITUTED HETEROCYCLICS WITH THERAPEUTIC ACTIVITY IN HIV CD4, NFATC1, PAICS HSP90AA1 2225/4885HSP90AB1 1833/4885PIK3CA 1871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback